Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Mezzion Pharma (140410 KS)
Watchlist
15
Analysis
Health Care
•
South Korea
Mezzion Pharma Co Ltd develops pharmaceutical products and out-licenses them to foreign countries including Canada, Mexico, Russia, and the United States. The Company's main products are for benign prostatic hyperplasia and erectile dysfunction.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Quantitative Analysis
•
16 Oct 2019 06:41
Korea - The Shorts Must Be Crazy (On Some Names)!
The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 11 October.Current...
Brian Freitas
Follow
406 Views
Share
bullish
•
MSCI Emerging Markets Index
•
26 Aug 2018 23:31
EM Strategy: Remain Overweight India
In this report we provide a synopsis of EM markets. We also scour the EM universe for attractive and actionable opportunities, highlighting...
Vermilion Research
Follow
431 Views
Share
bullish
•
Thematic (Sector/Industry)
•
01 Jun 2017 14:39
Summary of KOSPI200 & KOSDAQ150 Upcoming Reshuffle
As I said in my earlier comment, Samsung Biologics Co., Ltd (207940 KS) seems to be benefiting a lot from its inclusion in KOSPI200 index. Perhaps...
Sanghyun Park
Follow
2.2k Views
Share
bullish
•
Thematic (Sector/Industry)
•
07 Jul 2016 00:13
SillaJen's December IPO: Valuation, Growth Expectation and IPO Timing
SillaJen Biotherapeutics (established in 2006) is indeed a rare breed in Korean pharmaceutical world. It is not a generic drug maker. It is not a...
Sanghyun Park
Follow
3.5k Views
Share
First
Previous
1
2
3
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3
x